microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity

被引：0
|
作者：
Elizabeth C Martin
Lyndsay V Rhodes
Steven Elliott
Adrienne E Krebs
Kenneth P Nephew
Erik K Flemington
Bridgette M Collins-Burow
Matthew E Burow
机构：
[1] Tulane University,Department of Medicine
[2] Tulane University,Section of Hematology and Medical Oncology
[3] Tulane University,Department of Pharmacology
[4] Tulane University,The Center for Bioenvironmental Research
[5] Indiana University School of Medicine,Department of Pathology
来源：
Molecular Cancer | / 13卷
关键词：
miR-155; mTOR; breast cancer; miRNA; Estrogen receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 43 条
  • [21] Mammalian Target of Rapamycin (mTOR) Activity Dependent Protein Expression and Rapamycin Sensitivity in Pediatric Acute Lymphoblastic Leukemias
    Sebestyen, A.
    Nemes, K.
    Mark, A.
    Varadi, Z.
    Hajdu, M.
    Sticz, T.
    Kopper, L.
    Kovacs, G.
    Csoka, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S641 - S641
  • [22] The mammalian target of rapamycin inhibitor RAD001 (everolimus) in postmenopausal women with early breast cancer: results of a phase II pre-operative trial.
    Macaskill, E. J.
    Bartlett, J. M. S.
    White, S.
    Renshaw, L.
    Campbell, F. M.
    Young, O.
    Stumm, M.
    Faratian, D.
    Thomas, J. S.
    Barber, M. D.
    Dixon, J. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S286 - S287
  • [23] The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia
    Saunders, Philip
    Cisterne, Adam
    Weiss, Jocelyn
    Bradstock, Kenneth F.
    Bendall, Linda J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01): : 69 - 77
  • [24] Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non-small cell lung cancer
    Johnson, Bruce E.
    Jackman, David
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4628S - 4631S
  • [25] Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition
    Goudar, RK
    Shi, Q
    Hjelmeland, MD
    Keir, ST
    McLendon, RE
    Wikstrand, CJ
    Reese, ED
    Conrad, CA
    Traxler, P
    Lane, HA
    Reardon, DA
    Cavenee, WK
    Wang, XF
    Bigner, DD
    Friedman, HS
    Rich, JN
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (01) : 101 - 112
  • [26] Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001
    Baumann, Philipp
    Hagemeier, Hilke
    Mandl-Weber, Sonja
    Franke, Daniel
    Schmidmaier, Ralf
    ANTI-CANCER DRUGS, 2009, 20 (04) : 259 - 266
  • [27] A phase II study of mammalian target of rapamycin (mTOR) inhibitor RAD001 plus imatinib mesylate (IM) in patients with previously treated advanced renal carcinoma (RCC)
    Chan, J. S.
    Vuky, J.
    Besaw, L. A.
    Beer, T. M.
    Ryan, C. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Combination therapy of inhibitors of the epidermal growth factor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.
    Goudar, R
    Keir, S
    Hjelmeland, M
    Conrad, C
    Traxler, P
    Lane, H
    Wang, XF
    Bigner, DD
    Friedman, HS
    Rich, JN
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6090S - 6090S
  • [29] Regulation of peroxisome proliferator-activated receptor-γ activity by mammalian target of rapamycin and amino acids in adipogenesis
    Kim, JE
    Chen, J
    DIABETES, 2004, 53 (11) : 2748 - 2756
  • [30] Concurrent Histone Deacetylase and Mammalian Target of Rapamycin Inhibition Attenuate Androgen Receptor and Hypoxia Signaling Associated With Alterations in MicroRNA Expression
    Ellis, L.
    Lehet, K.
    Ramakrishnan, S.
    Miles, K. M.
    Wang, D.
    Liu, S.
    Atadja, P.
    Carducci, M. A.
    Pili, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S501 - S501
12345